61M, trading at HK$0.45 on the HKSE. This SniperIQ fundamentals page covers UMP Healthcare Holdings's valuation (P/E 10.9x, P/B 0.5x), profitability (net margin 4.4%), revenue (HK$727M in FY2024), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK
61M
P/E (TTM)10.9x
Net Margin4.4%
Revenue (FY24)HK$727M

Full research coverage

Frequently Asked Questions

What is UMP Healthcare Holdings's market cap?

UMP Healthcare Holdings (0722) has a market capitalization of approximately HK

61M, trading at HK$0.45 on the HKSE. Market cap moves with the live share price.

What is UMP Healthcare Holdings's P/E ratio?

UMP Healthcare Holdings's trailing twelve-month P/E ratio is 10.9x, with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is UMP Healthcare Holdings?

UMP Healthcare Holdings runs a net profit margin of 4.4%, a gross margin of 67.8%, and an operating margin of 29.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does UMP Healthcare Holdings generate?

UMP Healthcare Holdings reported revenue of HK$727M for fiscal year 2024, with net income of HK

1M and earnings per share (EPS) of 0.0398. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does UMP Healthcare Holdings pay a dividend?

UMP Healthcare Holdings offers a trailing dividend yield of about 7.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is UMP Healthcare Holdings financially healthy?

UMP Healthcare Holdings carries a debt-to-equity ratio of 0.15x and a current ratio of 2.02x, with a market beta of 0.31. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is UMP Healthcare Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For UMP Healthcare Holdings (0722) the key facts are: market cap HK

61M, P/E 10.9x, revenue HK$727M, 52-week range 0.44-0.53. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track UMP Healthcare Holdings's full fundamentals live

Get UMP Healthcare Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.